Reveal Biosciences is creating a new generation of data powered pathology to enhance research and improve global healthcare.
Cancer has impacted the lives of many of our friends and family. Reveal was founded in 2012 by Claire Weston and Casey Laris with a vision towards pathology driven by data. Our team is creating artificial intelligence technologies for whole slide pathology images that increase accuracy, reproducibility and scale. If the technology we’re building today had been available 15 years ago, a cancer misdiagnosis in Casey’s own family would likely have been caught. We see that by taking a quantitative approach, the data generated by our tools benefits preclinical research, clinical trials, and ultimately patients.
We are proud to partner with the following organizations
Latest research, in the news, or at events.
Reveal Biosciences Creates A New Artificial Intelligence Approach to Spatial Genomics in Partnership with QuantumCyte
The partnership paves way for the integration of AI-driven spatial genomics with a unique cloud-based platform (SAN DIEGO, Jan. 19, 2021) — Reveal Biosciences, Inc., a leader in AI
Reveal Biosciences’ AI-powered imageDx™ platform expedites pathology review of over 3,500 slides for COVID study
The universal demand to bring a COVID vaccine to market has expedited timelines in both preclinical and clinical research. While vaccine development efforts have been accelerated, traditional pathology evaluation
imageDx™ platform creates a new generation of Pathology Intelligence™ (SAN DIEGO, CA. Jan. 12, 2021) — Reveal Biosciences, Inc., an established AI data provider, has developed a powerful and